1. Home
  2. CTKB vs NNNN Comparison

CTKB vs NNNN Comparison

Compare CTKB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.74

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$8.49

Market Cap

434.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
NNNN
Founded
1990
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.1M
434.5M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CTKB
NNNN
Price
$4.74
$8.49
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$5.63
N/A
AVG Volume (30 Days)
791.4K
32.9K
Earning Date
05-07-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,015,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
$446.57
Revenue Growth
17.67
N/A
52 Week Low
$3.28
$8.30
52 Week High
$6.18
$54.50

Technical Indicators

Market Signals
Indicator
CTKB
NNNN
Relative Strength Index (RSI) 58.18 31.56
Support Level $4.15 N/A
Resistance Level $5.24 $12.62
Average True Range (ATR) 0.22 2.18
MACD 0.04 0.09
Stochastic Oscillator 73.03 12.20

Price Performance

Historical Comparison
CTKB
NNNN

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: